Acute Myelomonoblastic Leukemia Carrying the PEBP2β/MYH11 Fusion Gene

References

• First MIC Cooperative Study Group. Morphologic, immunologic, and cytogenetic (MIC) working classification of acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics 1986; 23: 189–197
   PubMed Web of Science ®Google Scholar
• Second MIC Cooperative Study Group. Morphologic, immunologic, and cytogenetic (MIC) working classification of the acute myeloid leukemias. Cancer Genetics and Cytogenetics 1988; 30: 1–15
   PubMed Web of Science ®Google Scholar
• Heim S., Mitelman F. Cancer cytogenetics, 2nd ed. Wiley-Liss, Inc., New York 1995; 69–140
   Google Scholar
• Arthur D.C., Berger R., Golomb H.M., Swansbury G.L., Reeves B.R., Alimena G., van den Berghe H., Bloomfield C.D., de la Chapelle A., Dewald G.W., Garson O.M., Hagemeijier A., Kaneko Y., Mitelman F., Pierre R.V., Ruutu T., Sakurai M., Lawler S.D., Rowley L.D. The clinical significance of karyotype in acme myelogenous leukemia. Cancer Genetics and Cytogenetics 1989; 40: 203–216
   PubMed Web of Science ®Google Scholar
• Schiffer C.A., Lee E.J., Tomiyasu T., Wiernik P.H., Testa J.R. Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia. Blood 1989; 73: 263–270
   PubMed Web of Science ®Google Scholar
• Swansbury G.J., Lawler S.D., Alimena G., Arthur D., Berger R., van den Berghe H., Bloomfield C.D., de la Chapelle A., Dewald G., Garson O.M., Hagemeijer A., Mitelman F., Rowley J.D., Sakurai M. Long-term survival in acute myelogenous leukemia: A second follow-up of the Fourth International Workshop on Chromosomes in Leukemia. Cancer Genetics and Cytogenetics 1994; 73: 1–7
   PubMed Web of Science ®Google Scholar
• Arthur D.C., Bloomfield C.D. Partial deletion of the long arm of chromosome 16 and bone marrow eosinophilia in acute nonlymphocytic leukemia: a new association. Blood 1983; 61: 994–998
   PubMed Web of Science ®Google Scholar
• Le Beau M.M., Larson R.A., Bitter M.A., Vardiman J.W., Golomb H.M., Rowely J.D. Association of an inversion of chromosome 16 with abnormal marrow eosinophilia. New England Journal of Medicine 1983; 309: 630–636
   PubMed Web of Science ®Google Scholar
• Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A.G., Gralnick H.R., Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. Annals of Internal Medicine 1985; 103: 626–629
   PubMedGoogle Scholar
• Larson R.A., Williams S.F., Le Beau M.M., Bitter M.A., Vardiman J.W., Rowely J.D. Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis. Blood 1986; 68: 1242–1249
   PubMed Web of Science ®Google Scholar
• Holmes R., Keating M.J., Cork A., Broach Y., Trujillo J., Dalton J.W.T., McCredie K.B., Freireich E.J. A unique pattern of central nervous system leukemia in acute myelomonocytic leukemia associated with inv(16)(p13q22). Blood 1985; 65: 1071–1078
   PubMed Web of Science ®Google Scholar
• Liu P., Tarle S.A., Hajra A., Claxton D.F., Marlton P., Freedman M., Siciliano M.J., Collins F.S. Fusion between transcriptinal facter CBFβ/PEBP2β and myosin heavy chain in acute myeloid leukemia. Science 1993; 261: 1041–1044
   PubMed Web of Science ®Google Scholar
• Langabeer S.E., Walker H., Gale R.E., Wheatley K., Burnett A.K., Goldstone A.H., Linch D.C. Frequency of CBFβ/MYH11 fusion transcripts in patients entered into the U.K. MRC AML trials. British Journal of Haematology 1997; 96: 736–739
   PubMed Web of Science ®Google Scholar
• Claxton D.F., Liu P., Hsu H.B., Marlton P., Hester J., Collins F., Deisseroth A.B., Rowley J.D., Siciliano M.J. Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia. Blood 1994; 83: 1750–1756
   PubMed Web of Science ®Google Scholar
• Poirel H., Radford-Weiss I., Rack K., Troussard X., Veil A., Valensi F., Picard F., Guesnu M., Leboeuf D., Melle J., Dreyfus F., Flandrin G., Macintyre E. Detection of the chromosome 16 CBFβ-MYH11 fusion transcript in myelomonocytic leukemia. Blood 1995; 85: 1313–1322
   PubMed Web of Science ®Google Scholar
• Shurtleff S.A., Meyers S., Hiebert S.W., Raimondi S.C., Head D.R., Willman C.L., Wolman S., Slovak M.L., Carroll A.J., Behm F., Hulshof M.G., Motoroni T.A., Okuda T., Liu P., Collins F.S., Downing J.R. Heterogeneity in CBFβ/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia. Blood 1995; 85: 3695–3703
   PubMed Web of Science ®Google Scholar
• van der Reijden B.A., Lombardo M., Dauwerse H.G., Giles R.H., Muhlematter D., Bellomo M.J., Wessels H.W., Beverstock G.C., van Ommen G-J.B., Hagemeijer A., Breuning M.H. RT-PCR diagnosis of patients with acute nonlymphocytic leukemia and inv(16)(p13q22) and identification of new alternative splicing in CBFB-MYH11 transcripts. Blood 1995; 86: 277–282
   PubMed Web of Science ®Google Scholar
• Costello R., Sainty D., Lecine P., Cusenier A., Mozziconacci M-J., Arnoulet C., Maraninchi D., Gastaut J-A., Imbert J., Lafage-Pochitaloff M., Gabert J. Detection of CBFβ/MYH11 fusion transcripts myeloid leukemia: heterogeneity of cytological and molecular characteristics. Leukemia 1997; 11: 644–650
   PubMed Web of Science ®Google Scholar
• Hebert J., Cayuela J.M., Daniel M.T., Berger R., Sigaux F. Detection of minimal residual disease in acute in acute myelomonocytic leukemia with abnormal marrow eosinophils by nested polymerase chain reaction with allele specific amplification. Blood 1994; 84: 2291–2296
   PubMed Web of Science ®Google Scholar
• Matsuoka R., Yoshida M.C., Furutani Y., Imamura S., Kanda N., Yanagisawa M., Masaki T., Takao A. Human smooth muscle myosin heavy chain gene mapped to chromosomal region 16q12. American Journal of Medical Genetics 1993; 46: 61–67
   PubMed Web of Science ®Google Scholar
• Ogawa E., Inuzuka M., Maruyama M., Satake M., Naito-Fujimoto M., Ito Y., Shigesada K. Molecular cloning and characterization of PEBP2β the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2α. Virology 1993; 194: 314–331
   PubMed Web of Science ®Google Scholar
• Wang S., Wang Q., Crute B.E., Melnikova I.N., Keller S.R., Speck N.A. Cloning and characterization of sub-unit of the T-cell recepter and murine leukemia virus enhancer core-binding facter. Molecular and Cellular Biology 1993; 13: 3324–3339
   PubMed Web of Science ®Google Scholar
• Ogawa E., Maruyama M., Kagoshima H., Inuzuka M., Lu J., Satake M., Shigesada K., Ito Y. PEBP2/PEA2 represents a family of transcription factors homologous to the Drosophila runt gene and the human AML1 gene. Proceedings of the National Academy of Sciences USA 1993; 90: 6859–6863
   PubMed Web of Science ®Google Scholar
• Bae S.C., Yamaguchi-Iwai Y., Ogawa E., Maruyama M., Inuzuka M., Kagoshima H., Shigesada K., Satake M., Ito Y. Isolation of PEBP2αB cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1. Oncogene 1993; 8: 809–814
   PubMed Web of Science ®Google Scholar
• Miyoshi H., Shimizu K., Kozu T., Maseki N., Kaneko Y., Ohki M. The t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia clustered within a limited region of a novel gene, AML1. Proceedings of the National Academy of Sciences VSA 1991; 88: 10431–10434
   PubMed Web of Science ®Google Scholar
• Nucifora G., Birn D., Espinosa R., LeBeau M., Erickson P., Roulston D., McKeithan T.W., Drabkin H., Rowley J.D. Involvement of the AML1 gene in t(3;21) in therapy-related leukemia and in chronic myeloid leukemia in blast crisis. Blood 1993; 81: 2728–2734
   PubMed Web of Science ®Google Scholar
• Mitani K., Ogawa S., Tanaka T., Miyoshi H., Kurokawa M., Mano H., Yazaki Y., Ohki M., Hirai H. Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. The EMBO Journal 1994; 13: 504–510
   PubMed Web of Science ®Google Scholar
• Romana S.P., Poirel H., Leconiat M., Flexor M.A., Mauchauffe M., Jonvenux P., Macintyre E.A., Berger R., Bernard O.A. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 1995; 86: 4263–4269
   PubMed Web of Science ®Google Scholar
• Golub T.R., Barker G.F., Bohlander S.K., Hiebert S.W., Ward D.C., Bray-Ward P., Morgan E., Raimondi S.C., Rowley J.D., Gilliiland D.G. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proceedings of the National Academy of Sciences USA 1995; 92: 4917–41921
   PubMed Web of Science ®Google Scholar
• Levanon D., Negreanu V., Bernstein Y., Bar-Am I., Avivi L., Groner Y. AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 1994; 23: 425–432
   PubMed Web of Science ®Google Scholar
• Meyers S., Lenny N., Sun W., Hiebert S.W. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia. Oncogene 1996; 13: 303–312
   PubMed Web of Science ®Google Scholar
• Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., Sato M., Okamoto R., Kitamura Y., Yoshiki S., Kishimoto T. Targeted disruption of Cbfal results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997; 89: 755–764
   PubMed Web of Science ®Google Scholar
• Mundlos S., Otto F., Mundlos C., Mulliken J.B., Aylsworth A.S., Albright S., Lindhout D., Cole W.G., Henn W., Knoll J.H.M., Owen M.J., Mertelsmann R., Zabel B.U., Olsen B.R. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 1997; 89: 773–779
   PubMed Web of Science ®Google Scholar
• J Osato M., Asou N., Okubo T., Nishimura S., Yamasaki H., Era T., Suzushima H., Kawano F., Matsuoka R., Oka H., Bae S.C., Ito Y., Takatsuki K. Myelomonoblastic leukaemia cells carrying the PEBPβ/MYH11 fusion gene are CD34+, c-KIT+ immature cells. British Journal of Haematology 1997; 97: 656–658
   PubMed Web of Science ®Google Scholar
• Era T., Asou N., Kunisada T., Yamasaki H., Asou H., Kamada N., Nishikawa S., Yamaguchi K., Takatsuki K. Identification of two transcripts of AML1/ETO-fused gene in t(8;21) leukemic cells and expression of wild-type ETO gene in hematopoietic cells. Genes, Chromosomes & Cancer 1995; 13: 25–33
   PubMed Web of Science ®Google Scholar
• Liu P.P., Hajra A., Wijimenga C., Collin F.S. Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia. Blood 1995; 85: 2289–2302
   PubMed Web of Science ®Google Scholar
• Marlton P., Claxton D.F., Liu P., Estey E.H., Berran M., Le Beau M., Testa J.R., Collins F.S., Rowley J.D., Siciliano M.J. Molecular characterization of 16p deletions associated with inversion 16 defines the critical fusion for leukemogenesis. Blood 1995; 85: 772–779
   PubMed Web of Science ®Google Scholar
• Kuss B.J., Deeley R.G., Cole S.P., Willman C.L., Kopecky K.J., Wolman S.R., Eyre H.J., Lane S.A., Nancarrow J.K., Whitmore S.A., Callen D.F. Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications. Lancet 1994; 343: 1531–1534
   PubMed Web of Science ®Google Scholar
• vanderReijden B.A., Martinet D., Dauwerse J.G., Giles R.H., Wessels J.W., Beverstock G.C., Smit B., Muhlematter D., Bellomo M.J., Gabert J., Lafage-Pochitaloff M., Reiffers J., Bilhou-Nabera C., van Ommen G.J.B., Hagemeijer A., Breuning M.H. Simple method for detection of MYH11 DNA rearrangements in patients with inv(16)(p13q22) and acute myeloid leukemia. Leukemia 1996; 10: 1459–1462
   PubMed Web of Science ®Google Scholar
• Morinaga S., Osato M., Yanabe Y., Takaki K., Kawano F., Asou N., Takatsuki K., Tsuchiya H., Matsuda I. Detection of PEBP2β/MYH11 fusion mRNA in acute myelomonocytic leukemia without marrow eosinophilia. Rinsho Ketsueki 1996; 37: 618–623
   PubMedGoogle Scholar
• Asou N., Sanada I., Tanaka K., Hidaka H., Suzushima H., Matsuzaki H., Kawano F., Takatsuki K. Inversion of chromosome 16 and bone marrow eosinophilia in a myelomonocytic transformation of chronic myeloid leukemia. Cancer Genetics and Cytogenetics 1992; 61: 197–200
   PubMed Web of Science ®Google Scholar
• Yamasaki H., Era T., Asou N., Sanada I., Matutes E., Yamaguchi K., Takatsuki K. High degree of myeloid differentiation and granulocytosis is associated with t(8;21) smoldering leukemia. Leukemia 1995; 9: 1147–1153
   PubMed Web of Science ®Google Scholar
• Miyamoto T., Akashi K., Hayashi S., Oogami A., Okamura T., Iwasaki H., Murakami M., Harada M., Niho Y. Pericentric inversion of chromosome 16 and eosinophilia in chronic myelomonocytic leukemia. Cancer Genetics and Cytogenetics 1997; 94: 99–102
   PubMed Web of Science ®Google Scholar
• Quesnel B., Kantarrijian H., Bjergaad J.P., Brault P., Estey E., Lai J.L., Tilly H., Stoppa A.M., Archimbaud E., Harousseau J.L., Bauters F., Fenaux P. Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature. Journal of Clinical oncology 1993; 11: 2370–2379
   PubMed Web of Science ®Google Scholar
• Osato M., Asou N., Takata N., Suzushima H., Takatsuki K. Detection of the PEBP2β/MY11 fusion transcript in acute myelomonoblastic leukemia (M4Eo) supervening in a patient with adult T-cell leukemia. American Journal of Hematology 1997; 55: 216–217
   PubMed Web of Science ®Google Scholar
• Adriaansen H.J., te Boekhorst P.A.W., Hagemeijer A.M., van der Schoot C.E., Delwel H.R., van Dongen J.J.M. Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression. Blood 1993; 81: 3043–3051
   PubMed Web of Science ®Google Scholar
• Terstappen L. W. M. M., Huang S., Shafford M., Lansdorp P.M., Lorken M.R. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38+ progenitor cells. Blood 1991; 11: 1218–1227
   Google Scholar
• He X.Y., Antao V.P., Basila D., Marx I.C., Davis B.R. Isolation and molecular characterization of the human CD34 gene. Blood 1992; 79: 2296–2302
   PubMed Web of Science ®Google Scholar
• Burn T.C., Satterthwaite A.B., Tenen D.G. The human CD34 hematopoietic stem cell antigen promoter and a 3′ enhancer direct hematopoietic expression in tissue culture. Blood 1992; 80: 3051–3059
   PubMed Web of Science ®Google Scholar
• Nagai R., Larson D.M., Periasamy M. Characterization of a mammalian smooth muscle heavy chain cDNA clone and its expression in various smooth muscle types. Proceedings of the National Academy Sciences USA 1988; 85: 1047–1051
   PubMed Web of Science ®Google Scholar
• Kiehart D.P. Molecular genetic dissection of myosin heavy chain function. Cell 1990; 60: 347–350
   PubMed Web of Science ®Google Scholar
• Kagoshima H., Akamatsu Y., Ito Y., Shigesada K. Functional Dissection of the a and β subunits of transcription factor PEBP2 and the redox susceptibility of its DNA binding activity. Journal of Biological Chemistry 1996; 211: 33074–33082
   Google Scholar
• Lu J., Maruyama M., Satake M., Bae S.C., Ogawa E., Kagoshima H., Shigesada K., Ito Y. Subcellular localization of the α and β subunits of the acute myeloid leukemia-linked transcription factor PEBP2/CBF. Molecular and Cellular Biology 1995; 15: 1651–1661
   PubMed Web of Science ®Google Scholar
• Ito Y. Structural alterations in the transcription factor PEBP2/CBF linked to four different types of leukemia. Journal of Cancer Research and Clinical Oncology 1996; 122: 266–274
   PubMed Web of Science ®Google Scholar
• Satake M., Inuzuka M., Shigesada K., Oikawa K., Ito Y. Differential expression of subspecies of polyomavirus and murine leukemia virus enhancer core binding protein, PEBP2, in various hematopoietic cells. Japanese Journal of Cancer Research 1992; 83: 714–722
   PubMedGoogle Scholar
• Cameron S., Taylor D.S., TePas E.C., Speck N.A., Mathey-Prevot B. Identification of a critical regulatory site in the human interleukin-3 promoter by in vivo foot-printing. Blood 1994; 83: 2851–2859
   PubMed Web of Science ®Google Scholar
• Takahashi A., Satake M., Yamaguchi I.Y., Bae S-C., Lu J., Maruyama M., Zhang U.W., Oka H., Arai N., Arai K., Ito Y. Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promoter activity by AMLl-related transcription factor, PEBP2. Blood 1995; 86: 607–616
   PubMed Web of Science ®Google Scholar
• Nuchprayoon I., Meyers S., Scott L.M., Suzow J., Hiebert S., Friedman A.D. PEBP2/CBF, the murine homolog of the human myeloid AML-1 and PEBP2β/CBFβ proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Molecular and Cellular Biology 1994; 14: 5558–5568
   PubMed Web of Science ®Google Scholar
• Okuda T., van Deursen J., Hiebert S.W., Grosveld G., Downing J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 1996; 84: 321–330
   PubMed Web of Science ®Google Scholar
• Wang Q., Stacy T., Binder M., Marin-Padilla M., Sharpe A.H., Speck N.A. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proceedings of the National Academy of Sciences USA 1996; 83: 3444–3449
   Web of Science ®Google Scholar
• Wang Q., Stacy T., Miller J.D., Lewis A.F., Gu T-L., Huang X., Bushweller J.H., Bones J-C., Alt F.W., Ryan G., Liu P.P., Wynshaw-Boris A., Binder M., Marin-Padilla M., Sharpe A.H., Speck N.A. The CBFβ subunit is essential for CBFα2 (AML1) function in vivo. Cell 1996; 87: 697–708
   PubMed Web of Science ®Google Scholar
• Sasaki K., Yagi H., Bronson R.T., Tominaga K., Matsunashi T., Deguchi K., Tani Y., Kishimoto T., Komori T. Absence of fetal liver hematopoiesis in mice deficient in transcriptional cofactor core binding factor p. Proceedings of the National Academy of Sciences USA 1996; 93: 12359–12363
   PubMed Web of Science ®Google Scholar
• Yergeau D.A., Hetherington C.J., Wang Q., Zhang P., Sharpe A.H., Binder M., Marin-Padilla M., Tenen D.G., Speck N.A., Zhang D-E. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML-ETO fusion gene. Nature Genetics 1997; 15: 303–306
   PubMed Web of Science ®Google Scholar
• Castilla L.H., Wijmenga C., Wang Q., Stacy T., Speck N.A., Eckhaus M., Marin-Padilla M., Collins F.S., Wynshaw-Boris A., Liu P.P. Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell 1996; 87: 687–696
   PubMed Web of Science ®Google Scholar
• Sakakura C., Yamaguchi-Iwai Y., Satake M., Bae S.C., Takahashi A., Ogawa E., Hagiwara A., Takahashi T., Murakami A., Makino K., Nakagawa T., Kamada N., Ito Y. Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8(ETO)-specific antisense oligonucleotide. Proceedings of the National Academy of Sciences USA 1994; 91: 11723–11727
   PubMed Web of Science ®Google Scholar